New research published in Cell Death & Disease covers the first batch of results from collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and ...
Dec 1, 2022
0
4
Researchers at National Jewish Health have shown that vapor from electronic cigarettes increases small airway inflammation response to influenza A infections. The findings show that short-term exposure of just three days ...
Nov 14, 2022
0
11
An international team of researchers has revealed how scarring occurs in long COVID and pulmonary fibrosis using innovative blood biomarkers and X-ray technology. This study, published in eBioMedicine, contributes to the ...
Nov 2, 2022
0
5
Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical ...
Oct 13, 2022
1
37
Idiopathic pulmonary fibrosis could become the first degenerative disease to be treated through the science of aging.
Oct 6, 2022
0
54
In the last decade, timely and efficient diagnoses of idiopathic pulmonary fibrosis (IPF), a lethal disease that causes scarring of the lung tissue and affects the ability to breathe and be active, has become recognized as ...
Sep 29, 2022
0
17
A steering committee of pulmonary experts and primary care physicians (PCPs) released today a white paper outlining the issues surrounding delays in diagnosing interstitial lung diseases (ILDs) like pulmonary fibrosis (PF). ...
Sep 19, 2022
0
6
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
301
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive ...
Jul 28, 2022
0
5
The QUT Inspire ISy app, was developed by QUT Ph.D. candidate Clarence Baxter and has been tested and compared with a Triflo II clinical incentive spirometry device by 24 healthy participants with the study's results published ...
Jul 28, 2022
0
7
